AzTrials
AzTrials

Anemia, Iron-DeficiencyNCT02365103

Tea Consumption and Iron Bioavailability in Women Using a Stable Isotope

A study testing Test meal I (given with water), Test meal II (simultaneously with tea) and Test meal III (1 hour after test meal) in people with Anemia, Iron-Deficiency, run by University of Chester at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the inhibition effect of tea consumption on non haem iron absorption with the use of an iron tracer. The study also aims to assess the effect of time variability of tea consumption on non haem iron absorption from a typical western breakfast. Read more about this study

Who is it for?
Ages 19 to 40 years, women onlyHealthy volunteers can take part
Conditions the study is for
Anemia, Iron-Deficiency
What is being tested?
Test meal I (given with water), Test meal II (simultaneously with tea) and Test meal III (1 hour after test meal)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteUnited Kingdom
Study dates
Nov 2014to Mar 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 40 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • pre menopausal women;
  • aged 19- 40 years;
  • healthy;
  • non- pregnant nor lactating.

Who cannot join

  • history of gastrointestinal and metabolic disorders;
  • have donated blood within past 6 months;
  • regularly consuming nutritional supplements.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University of Chester

    Chester, Cheshire, CH1 4BJ

Other trials in United Kingdom

About this study

Official title: Investigation Into the Inhibitory Effects of Tea Consumption on Iron Bioavailability in a Cohort of Healthy United Kingdom (UK) Women, Using a Stable Iron Isotope

The purpose of this study is to investigate the inhibition effect of tea consumption on non haem iron absorption with the use of an iron tracer. The study also aims to assess the effect of time variability of tea consumption on non haem iron absorption from a typical western breakfast.

Read the detailed description

This is a non randomised controlled trial in 12 healthy participants over a period of 56 days. The study will investigate the inhibition effect of tea consumption on non haem iron absorption with the use of a stable iron isotope (Fe57) tracer. The study also aims to assess the effect of time variability of tea consumption on non haem iron absorption from a typical western breakfast.There is evidence of lower iron absorption when a meal is given with tea, compared to water. There is also evidence from previous studies that the inhibition effect is higher when tea is consumed simultaneously with a meal, compared to in between meals. However, there are limited number of human studies investigating iron absorption and time interval, particularly in the UK. The study aims to recruit 12 healthy participants. The test meals will be given together with black tea labelled with iron tracer, at various time intervals which includes together and after the meals. Test meal given with water will be used as a control. Blood samples will be collected 14 days post dosage for each of the meals. The study will take place at University of Chester, and participants will attend 5 clinics during the 56 day study. Prior to the start of study, participants will complete a 3 day food diary, where they will be given instructions by the researcher. In each clinic, weight and height will be measured, followed by a fasted blood sample and the administration of test meals.

PROJECT HYPOTHESES H1: There is a significant difference in non haem iron absorption from a typical western breakfast with tea consumption compared to without tea consumption H0:There is no significant difference in non haem iron absorption from a typical western breakfast with tea consumption compared to without tea consumption H1: Iron absorption will be lower when tea is consumed simultaneously with meals compared to when it is consumed in between meals H0: The iron absorption will not be lower when tea is consumed simultaneously with meals compared to when is consumed in between meals H1: There is an inverse correlation between tea consumption and iron status parameters H0: There is no inverse correlation between tea consumption and iron status parameters

There are several parameters which will be measured in this study. Height and weight will be measured using methods outlined in the Manual of Dietetic Practice using validated equipment (weighing scales and stadiometer). These will be measured by the student researcher at baseline and at each clinic (Clinic 1 to 5). Dietary intakes will be measured based on the data gathered in the 3 days food diary completed by the participants prior to Clinic 1 and 5. Additionally, blood samples will be taken by student researcher at each clinic. The analysis will be carried out in the Clinical Laboratories and Phlebotomy Room within the Department of Clinical Sciences and Nutrition (University of Chester), utilising the equipment and the clinical space where the participants will have to report during the administration of the meals with iron tracer. Test meals will be prepared in the food skills kitchen within the department. Analysis of blood samples will also be carried out in Clinical Sciences laboratories using relevant methodologies, including ELISA assays, bioanalysers and mass spectrometry. After the administration of meals labelled with iron tracers, all the blood samples will be stored at 80 Celsius in the laboratory until further analysis.

RECRUITMENT PROCESS The sampling will be carried out at the University of Chester. Posters/leaflets and letter/emails will be used as a medium of advertisement to the targeted group, especially to staff and students. The potential participants who require further information will be given participant information sheet which explains the procedure of the study.

STUDY PROCEDURE Clinic visits will take place between 0800 to 1000 (lasting for approximately 45 minutes) at the Clinical Sciences \& Nutrition laboratory, University of Chester. 5 clinics are required, with a time interval of 14 days between clinics to allow the incorporation of the stable iron isotope (Fe57) tracer into the blood. During each clinic, participants will be given test meals labelled with iron tracer and tea, and no food or drink will be allowed for the next 3 to 4 hours. All the containers used to administer the test meals will be washed with ultrapure water to make sure complete consumption of both test meals and iron tracer. Participants will attend each clinic after an overnight fast (10 hours), and 30 ml blood samples (6 teaspoons) will be collected at each clinic. All the clinic details are given below.

Clinic 1 (Day 0): Participants will complete a screening questionnaire, followed by physical measurements of height and weight. If they satisfy the inclusion criteria, they will be invited to participate in the study and be asked to sign an informed consent form. Participants will be asked about their food consumption over the previous 24 hours and will be required to complete 3 day food diary to reflect habitual intake. Participants will be given an explanation on how to record the dietary intake. Height and weight will be measured, followed by a baseline blood sample. This will be followed by consumption of the control test meal.

Clinic 2 (Day 14): Measurement of height and weight followed by a baseline blood sample and 24 hour food recall will be carried out. This will be followed by consumption of the test meal II with tea given simultaneously with the test meal.

Clinic 3 (Day 28): Measurement of height and weight followed by a baseline blood sample and 24 hour food recall will be carried out . This will be followed by consumption of the test meal III with tea given 1 hour after the test meal.

Clinic 4 (Day 42): Measurement of height and weight followed by a baseline blood sample and 24 hour food recall will be carried out . This will be followed by consumption of reference dose iron.

Clinic 5(Day 56): Prior to the completion of the study, participants will be given another 3 day food diary which has to be completed before the clinic for another assessment of dietary intake. Measurement of height and weight followed by a final blood sample drawn to measure the incorporation of iron from the reference dose and 24 hour food recall.

DATA-PLAN

Sample size determination and justification :

Sample size was estimated using iron absorption data (mean ± S.D) from a study by Derman et al. (1977) in which they reported iron absorption (%) of 6.7 ± 6.2 when the test meals were administered with tea and 34.0 ± 23.0 when the test meals were administered without tea. With an effect size of 1.324, the total sample size required in the proposed study is 10. Taking into account a 20% drop out rate, the total sample size required to demonstrate a significant difference in iron absorption between consumption of meal with and without tea is 12 (Power = 0.95).

Data Analysis :

All statistical analyses will be conducted by the research student with International Business Machines (IBM)® Statistical Package for the Social Sciences (SPSS)® Statistic Data Editor Software (Version 21). Values for iron absorption and meal ratios will be expressed as geometric means and standard deviations. Iron absorption values (in percentage) will be logarithmically transformed for the purpose of analyses and will then be retransformed to recover the original units (Hurrell et al., 1999). Assuming that the data is normally distributed after performing normality test (Shapiro Wilks), paired student t tests will be conducted (i) to compare the iron absorption from each pair of meals and (ii) to obtain the absorption ratios in the test meals in relative to the reference dose without meal. Pearson's correlation test will be performed to investigate the relationship between tea drinking and iron status biomarkers. A nonparametric approach will be adopted if the data is not normally distributed for all analyses. Differences will be considered significant with a p value < 0.05.

Being tested
Test meal I (given with water), Test meal II (simultaneously with tea), Test meal III (1 hour after test meal), Reference iron dose
Keywords
Anemia, Iron-Deficiency, Iron, Bioavailability, Hepcidins, Intestinal, Absorption, Isotope Labeling, Stable
Medical subject headings
Anemia, Iron-Deficiency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Test meal I (given with water)Other

    4 mg of the iron stable isotope, in a form of ferrous sulphate solution, extrinsically labelled in the test meal administered in the study, enrichment in the system will take approximately 14 days post dosing

  • Test meal II (simultaneously with tea)Other

    4 mg of the iron stable isotope, in a form of ferrous sulphate solution, extrinsically labelled in the test meal administered in the study, enrichment in the system will take approximately 14 days post dosing

  • Test meal III (1 hour after test meal)Other

    4 mg of the iron stable isotope, in a form of ferrous sulphate solution, extrinsically labelled in the test meal administered in the study, enrichment in the system will take approximately 14 days post dosing

  • Reference iron doseOther

    3 mg of the iron stable isotope, in a form of ferrous sulphate solution, extrinsically labelled and administered in the study, enrichment in the system will take approximately 14 days post dosing

Study groups in NCT02365103
Study groupRoleWhat they receive
Test meal I (given with water)OtherTest meal with water
Receives: Other: Test meal I (given with water)
Test meal II (simultaneously with tea)OtherTest meal with tea (simultaneously)
Receives: Other: Test meal II (simultaneously with tea)
Test meal III (1 hour after test meal)OtherTest Meal with tea given 1 hour after test meal
Receives: Other: Test meal III (1 hour after test meal)
Reference Iron DoseOtherReference iron dose administered
Receives: Other: Reference iron dose

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Iron absorption (%) measured by mass spectrometer

    Iron absorption is estimated based on the erythrocyte iron incorporation to the body system with the use of iron tracer after 14 days following administration of the test meals

    Measured: 14 days after each test meal

Secondary outcomes (8)
  1. Serum ferritin measured by Biomerieux mini VIDAS

    To assess the body iron storage

    Measured: 1 year

  2. Hepcidin measured by enzyme-linked immunosorbent assay (ELISA) kit

    To assess the mechanism involved in iron absorption

    Measured: 1 year

  3. Full blood count measured by Beckman Coulter Counter

    To assess the iron status

    Measured: 1 year

  4. Zinc protoporphyrin (ZPP) measured by haemato-fluorimetry

    To assess the iron status

    Measured: 1 year

  5. Total binding iron capacity (TIBC) measured by enzyme-linked immunosorbent assay (ELISA) kit

    To assess the total capacity of circulating transferrin bound to iron

    Measured: 1 year

  6. Transferrin saturation measured by enzyme-linked immunosorbent assay (ELISA) kit

    To assess the proportion of transferrin bound to iron

    Measured: 1 year

  7. Transferrin receptor measured by enzyme-linked immunosorbent assay (ELISA) kit

    To assess the severity of iron deficiency even in presence of inflammatory disorders

    Measured: 1 year

  8. C- reactive protein measured by enzyme-linked immunosorbent assay (ELISA) kit

    To assess levels of inflammation

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Feb 2015 (estimated)
  2. Study startNov 2014
  3. Primary completionMar 2015
  4. Study completionMar 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02365103
Sponsor's protocol ID
14/NW/0310 S-LS17042014
Status last verified
May 2019
First submitted
4 Feb 2015
Last updated
23 May 2019
Results posted
No
Data monitoring committee
No
Individual data sharing
No: The results are in the writing phase, and will be available in thesis form and possibly publication. It will be available in thesis form in 2017 and publication expected to be in 2018.

Publications

  • Ahmad Fuzi SF, Koller D, Bruggraber S, Pereira DI, Dainty JR, Mushtaq S. A 1-h time interval between a meal containing iron and consumption of tea attenuates the inhibitory effects on iron absorption: a controlled trial in a cohort of healthy UK women using a stable iron isotope. Am J Clin Nutr. 2017 Dec;106(6):1413-1421. doi: 10.3945/ajcn.117.161364. Epub 2017 Oct 18.

    PubMed 29046302

Questions about this trial

What is this clinical trial studying?

A study testing Test meal I (given with water), Test meal II (simultaneously with tea) and Test meal III (1 hour after test meal) in people with Anemia, Iron-Deficiency, run by University of Chester at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 May 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Iron absorption (%) measured by mass spectrometer (time frame: 14 days after each test meal). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02365103, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in